News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bitterman Robert J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Paid exercise price by delivering 917 shares
@ $1.51, valued at
$1.4k
|
|
| 07/05/2023 |
4
| Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 1,000 shares
@ $2.88, valued at
$2.9k
Bought 1,000 shares
@ $2.84, valued at
$2.8k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Bitterman Robert J (Interim Executive Chairman) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 2,000 shares
@ $0.39, valued at
$780 |
|
| 12/08/2022 |
4
| Bitterman Robert J (Interim Executive Chairman) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 2,000 shares
@ $0.39, valued at
$780 |
|
| 12/06/2022 |
4
| Bitterman Robert J (Interim Executive Chairman) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 2,000 shares
@ $0.43, valued at
$860 |
|
| 11/29/2022 |
4
| Bitterman Robert J (Interim Executive Chairman) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 2,500 shares
@ $0.42, valued at
$1.1k
Bought 215 shares
@ $0.4, valued at
$86 |
|
| 11/16/2022 |
4
| Bitterman Robert J (Interim Executive Chairman) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 1 shares
@ $1750, valued at
$1.8k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Bitterman Robert J (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
4
| Bitterman Robert J (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/03/2017 |
4
| Bitterman Robert J (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 08/27/2013 |
4
| Bitterman Robert J (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 08/05/2013 |
4
| Bitterman Robert J (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 06/11/2013 |
4
| Bitterman Robert J (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 03/01/2013 |
3
| Bitterman Robert J (Director) has filed a Form 3 on RXi Pharmaceuticals Corp |
| 02/14/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
|
|